03/31/2026
🎉 HUGE ACHIEVEMENT AT BIOFORTIS CLINICAL RESEARCH! 🎉
We are absolutely thrilled to announce the official and successful completion of our latest clinical trial. Under the expert guidance of our Study Investigator, Dr. Shah, our team just wrapped up a 6-week randomized crossover trial exploring the future of metabolic health.
We set out to evaluate how different doses and ingestion timings of a unique supplement impact the body's active GLP-1 hormonal and glycemic response following a meal.
Here is the most exciting part: We fully completed this trial with our target enrollment of 10 healthy adults, and we are proud to report that we had ZERO early terminations and ZERO adverse events!
Achieving a 100% completion rate with no adverse side effects over a rigorous 35-day study period—which required strict dietary tracking, multiple fasting clinical visits, and rigorous mixed-meal tolerance testing—is an incredible operational victory. This flawless ex*****on is a massive testament to the safety of the trial, the diligence of our clinical staff, and the outstanding commitment of our participants.
We can't wait to dive into the data and see what this means for the future of nutritional science!
A massive THANK YOU to our dedicated participants and our phenomenal research staff for making this trial a success!
